The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.

L. Talby , H. Chambost , M.C. Roubaud , C. N'Guyen , M. Milili (1) , B. Loriod , C. Fossat , C. Picard , J. Gabert , P. Chiappetta , G. Michel , C. Schiff (1)

1 CIML - Centre d'Immunologie de Marseille - Luminy

Domaines: Immunologie

L. Talby, H. Chambost, M.C. Roubaud, C. N'Guyen, M. Milili, et al.. The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.. Leukemia Research, 2006, 30, pp.665-676. ⟨hal-00080179⟩